Pathogenomix
Share
01/19/2022
Santa Cruz, CA: January 19th 2022 – Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has granted it a Breakthrough Device Designation for its Patho-Seq assay.
https://pathogenomix.com/pathogenomix_newsroom.aspx
Want your business to be the top-listed Engineering Company in Santa Cruz?
Click here to claim your Sponsored Listing.
Click here to claim your Sponsored Listing.
Category
Website
Address
499 Lake Avenue
Santa Cruz, CA
95062
